IBI – International Biopharmaceutical Industry

Current Edition

Volume 7 issue 1

Current Features

Current Features

Biotech Sector Survey: From Investment Confidence to Strategic Collaborations

In the rapidly evolving landscape, ICON’s recently published biotech sector survey provides a roadmap through the intricacies of investment confidence, funding dynam...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Extractables and Leachables for Inhaled Medicines

How risk assessments can improve E&L strategies Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) ar...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Using Predictive Compliance Risk Analysis to Avoid FDA Penalties

In the complex landscape of global regulations, particularly within healthcare and pharmaceutical sectors, a robust compliance strategy is essential for maintaining ...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Patients Are Waiting: Speeding Time to Treatment in Rare Disease

Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster. Rare diseases are no longer rare. Every year, people’s l...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Elevating Biomanufacturing Efficiencywith N-1 Perfusion Technology

In the dynamic world of biomanufacturing, the quest for improved efficiency and productivity continues to shape industry advancements. Among these innovations, the e...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Considerations on the Development and Manufacturing of Generic Peptides

The development of generic versions of peptides such as Semaglutide, the drug substance inside Novo Nordisk’s blockbuster drugs like Ozempic®, Rybelsus® or Wegovy®, ...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Advertisement

Current Edition

Volume 7 issue 1

Current Features

Biotech Sector Survey: From Investment Confidence to Strategic Collaborations

In the rapidly evolving landscape, ICON’s recently published biotech sector survey provides a roadmap through the intricacies of investment confidence, funding dynam...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Extractables and Leachables for Inhaled Medicines

How risk assessments can improve E&L strategies Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) ar...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Using Predictive Compliance Risk Analysis to Avoid FDA Penalties

In the complex landscape of global regulations, particularly within healthcare and pharmaceutical sectors, a robust compliance strategy is essential for maintaining ...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Patients Are Waiting: Speeding Time to Treatment in Rare Disease

Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster. Rare diseases are no longer rare. Every year, people’s l...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Elevating Biomanufacturing Efficiencywith N-1 Perfusion Technology

In the dynamic world of biomanufacturing, the quest for improved efficiency and productivity continues to shape industry advancements. Among these innovations, the e...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Considerations on the Development and Manufacturing of Generic Peptides

The development of generic versions of peptides such as Semaglutide, the drug substance inside Novo Nordisk’s blockbuster drugs like Ozempic®, Rybelsus® or Wegovy®, ...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Current Features

Ensuring Image Integrity When Reviewing Western Blots

Overcoming the Challenges Facing Editors and Publishers Western blots are frequently included in scientific papers to report results when analysing proteins in a ...

16 April 2024 Current Features | Volume 7 Issue 1

Continue Reading →

Company Profiles

A-D

Aurisco

Established in 1998, Aurisco is an innovative pharmaceutical company engaged in research, development, manufacturing and marketing of specialty APIs, formulations as...

11 March 2024 A-D | Company Profile

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte